RxDoctor Payments DataLook up a doctor →

Rebecca Thomas

Clinical Nurse Specialist · Akron, OHNPI 1518297704

Payments from drug & device makers

$6,459in general payments, 2019–2025

Across 326 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$946
  • Harmony Biosciences LLC$578
  • AstraZeneca$482
  • Inspire Medical Systems, Inc.$414
  • Biogen$366
  • Axsome Therapeutics, Inc.$337
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$6,06894%
  • Education$3916%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,459 in reported general payments places this provider in the 90th percentile of 97 clinical nurse specialist providers in Ohio.

See all clinical nurse specialist providers in Ohio

Medicare billing

Part B allowed, 2024
$22,060
Medicare patients
122
Services billed
210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate12$237,382
SunosiSolriamfetol Hcl15$14,112
BelsomraSuvorexant28$11,804
QuviviqDaridorexant Hcl18$8,153
Modafinil33$1,759
Gabapentin142$1,267
Trazodone Hcl169$922
Azelastine Hcl24$859
Armodafinil20$803
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine14$468
Doxepin Hcl38$370
Amitriptyline Hcl34$329
Fluticasone Propionate24$269
Mirtazapine14$213
Buspirone Hcl25$124

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Axsome Therapeutics, Inc.Sunosi$337$14,11215 claims
Idorsia Pharmaceuticals US IncQuviviq$141$8,15318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 97 clinical nurse specialist providers in Ohio.

Other clinical nurse specialist in Akron

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →